Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Incyte
Incyte
Incyte, itching for a piece of Dupixent's market, hits goals in midphase skin disease trial
Fierce Biotech
Mon, 03/11/24 - 11:52 am
Incyte
clinical trials
prurigo nodularis
povorcitinib
Dupixent
Sanofi
Regeneron
Incyte vets, with phase 1 within reach, raise $102M for new biotech to create better PARP, PI3K drugs
Fierce Biotech
Wed, 01/24/24 - 10:35 am
Synnovation Therapeutics
Incyte
AstraZeneca
GSK
Novartis
Pfizer
funding
cancer
PARP inhibitors
Incyte reports positive data from Phase III vitiligo trial
Clinical Trials Arena
Thu, 10/12/23 - 05:27 pm
Incyte
Opzelura
vitiligo
clinical trials
Replimune and Incyte to study cancer combo therapy in CSCC patients
Clinical Trials Arena
Tue, 08/1/23 - 10:06 am
Replimmune
Incyte
clinical trials
RP1
CSCC
cutaneous squamous cell carcinoma
Incyte’s trial of ruxolitinib cream meets primary endpoint
Clinical Trials Arena
Wed, 07/12/23 - 09:37 am
Incyte
ruxolitinib
clinical trials
pediatric
atopic dermatitis
Blood cancer trial finds ruxolitinib better than current treatments
Clinical Trials Arena
Fri, 05/5/23 - 10:13 am
clinical trials
polycythemia vera
Jakafi
Incyte
Incyte whittles down pipeline, scrapping 6 R&D programs
Fierce Biotech
Tue, 05/2/23 - 11:25 pm
Incyte
R7D
anemia
cancer
Biotech heads towards big catalysts
EP Vantage
Tue, 03/28/23 - 10:24 am
biotech
clinical trials
Alnylam Pharmaceuticals
Arcus Biosciences
Argenx
Arrowhead Pharmaceuticals
Axsome Therapeutics
Bavarian Nordic
FibroGen
Gilead Sciences
Incyte
Morphic Therapeutic
PTC Therapeutics
Syndax Pharmaceuticals
Travere Therapeutics
Vaxcyte
Incyte hit by CRL on extended-release JAK tablets, muddying plans for Jakafi franchise expansion
Endpoints
Fri, 03/24/23 - 10:05 am
Incyte
FDA
ruxolitinib
CRL
In a surprise approval, FDA green-lights Incyte's PD-1 inhibitor to treat rare cancer type
Fierce Pharma
Wed, 03/22/23 - 09:27 pm
Incyte
Zynyz
FDA
Merkel cell carcinoma
Incyte touts mid-stage data for new JAK inhibitor but stops short of selecting PhIII dose
Endpoints
Tue, 03/21/23 - 10:06 am
AAD
Incyte
JAK inhibitors
povorcitinib
vitiligo
Incyte reports data from Phase IIb vitiligo therapy trial
Clinical Trials Arena
Mon, 03/20/23 - 11:27 am
Incyte
povorcitinib
vitiligo
clinical trials
Incyte Abandons Phase III Trial for Myelofibrosis Treatment
BioSpace
Mon, 03/6/23 - 11:06 am
Incyte
clinical trials
myelofibrosis
Jakafi
Go or no go? Vaccines and neurology up for discussion
EP Vantage
Tue, 02/28/23 - 11:05 am
FDA
Acadia Pharmaceuticals
Apellis Pharmaceuticals
AstraZeneca
Biogen
Biomarin
Cidara Therapeutics
Emergent BioSolutions
GSK
Incyte
Ionis Pharmaceuticals
Melinta Therapeutics
Mundipharma
Novartis
Pfizer
Pharming
Regeneron
Roche
vaccines
RSV
ALS
COVID-19
Incyte reports new data from hidradenitis suppurativa therapy trial
Clinical Trials Arena
Mon, 02/13/23 - 10:25 am
Incyte
clinical trials
hidradenitis suppurativa
povorcitinib
Insmed, Alnylam and others make Science's list of top 20 biopharma employers
Endpoints
Sun, 11/6/22 - 01:32 pm
employers
Inbsmed
Alnylam
Regeneron
Incyte
SITC 2022 preview – cytokines and oral checkpoints
EP Vantage
Thu, 10/6/22 - 10:39 am
SITC
Incyte
ChemoCentryx
Amgen
cytokines
Incyte pays out $70M to get hands on Medicxi-backed vitiligo biotech
Endpoints
Mon, 10/3/22 - 10:21 am
Incyte
M&A
Villaris Therapeutics
vitiligo
Medicxi
FDA Action Alert: Incyte, Arcutis Await Decisions in Vitiligo, Psoriasis
BioSpace
Mon, 07/18/22 - 10:22 am
FDA
Incyte
Arcutis Biotherapeutics
Opzelura
vitiligo
roflumilast
psoriasis
MorphoSys Adds HIBio to Busy Collaboration Week
BioSpace
Wed, 06/15/22 - 11:03 am
MorphoSys
HIBio
Pfizer
Incyte
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »